Understanding the interplay between APO E polymorphism and cognition in the Italian oldest old: results from the "Mugello study"

Neurol Sci. 2024 Feb;45(2):539-546. doi: 10.1007/s10072-023-07073-4. Epub 2023 Sep 15.

Abstract

Introduction: Recent data suggest that the deleterious effect on general health and cognition of ε4 allele of Apolipoprotein E (ApoE) observed in the elderly population, may attenuate in extreme aging. This study aimed to describe the ApoE genotype distribution and its relationship with cognition in a group of nonagenarians living in the Mugello area, Italy.

Material and methods: Cognition was evaluated using the Mini-Mental-State-Examination (MMSE). DNA was extracted from blood samples to determine ApoE genotyping. Participants were classified into three ApoE groups (ε2, ε3, ε4). Logistic and linear regression models were created, to assess the relationship between ApoE genotype group and dementia diagnosis and cognitive performance, respectively.

Results: 169 subjects were included. ApoE ε3 was the most prevalent genotype (76.3%). Dementia prevalence was 26.6% and it was not associated with the presence of ApoE ε4. Participants of ε4 group were significantly more likely to have lower cognitive performances than ε2 and ε3, independently of a dementia diagnosis.

Discussion: Results support that ApoE genotype no longer plays a role in the health condition of the oldest old, however, an interaction is detectable between ApoE polymorphism and cognitive performances at this extreme age.

Keywords: Apolipoprotein E; Brain aging; Genetics; Mini-Mental-State-Examination; Nonagenarians.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Apolipoprotein E4 / genetics
  • Apolipoproteins E* / genetics
  • Cognition
  • Dementia*
  • Genotype
  • Humans
  • Polymorphism, Genetic / genetics

Substances

  • Apolipoprotein E4
  • Apolipoproteins E
  • ApoE protein, human